April 18, 2021
1 minutes read
Aurora Spinal column Corporation has actually revealed FDA 510 (k) clearance for the Apollo anterior cervical plate system, according to a news release.
This anterior cervical plate system (ACP) system is created to decrease postoperative issues after spine surgical treatment such as dysphagia, malalignment and ossification, according to the release.
” There are an approximated 180,000 cervical combination treatments carried out in the United States each year to ease compression on the spine or nerve roots. Getting FDA 510( k) clearance for the Apollo ACP system shows Aurora Spinal column’s dedication to provide ingenious, contemporary innovation for the anterior cervical spinal column and to support favorable medical results,” Trent Northcutt, president and CEO of Aurora Spinal column, stated in the release. “The launch of Apollo ACP is essential to our long-lasting cervical implant method and represents a considerable chance for development, as cervical spinal column treatments consist of an around $2.6 billion section of the international spinal column market.”
” This approval is an essential piece to the puzzle for advancing Aurora Spinal column’s essential effort of bringing more proprietary-based items to the market and reducing our dependence on third-party items,” Northcutt stated.
He included, “This approval is an excellent action for Aurora in financial 2021 and we are enthusiastic to provide a number of brand-new essential items throughout the year.”